MedTech Strategist

🌴☀️ Sunshine isn't the only thing you'll find in San Diego. Bringing together medtech investors and startups since 2013, the national Innovation Summit is making its rounds to San Diego, California this year. Over the past decade, the Innovation Summit Conference by MedTech Strategist has been attended by the most influential executives and ground-breaking startups in the medtech world. When you climb the summit at an Innovation Summit conference, you make unique connections, fundraise, and partner with the biggest players at medtech's longest running and most intimate conference. Join us in San Diego, California November 19-21, 2024 at The US Grant Hotel. Learn more here: https://bit.ly/4d2Ll0V #InnovationSanDiego #medtech #medicaldevices #medtechinnovation #medtechindustry #networking #conferences

What makes MedTech Strategist the leader of the pack in strategic #medtech industry information? Our publication allows you to: • Experience the excitement of exclusive interviews with visionary CEOs, influential executives, bold investors, and pivotal decision-makers • Be inspired by forward-thinking commentaries that challenge the status quo • Learn from real-world case studies that can transform your business strategy • Stay ahead with in-depth coverage of market trends, key players, and cutting-edge technologies that are revolutionizing #healthcare Let us know in the comments: how does MedTech Strategist give you the edge to guide your business strategy?

Last week, we learned that the Daniel and Jane Och Spine Hospital had a 99.8% success rate with 2,458 robotic screw placements, of which 0.2% or four screws were breached—making it significantly safer than freehand surgery. The breaches were all caused by trainees working on dysplastic pedicles, and all involved the use of high-speed burrs on the final or second to last screws. In response to these events, Columbia undertook multiple steps at the divisional, institutional, and individual level to reduce surgical complications (see Figure 2 & 3). In a summary discussion of new technologies, Tyler Koski, MD, associate professor of neurological and orthopedic surgery and director of spine surgery at Northwestern Medicine, noted that given the technologies available, “We are in a time now where screw misplacement really isn’t tolerated … which puts the  onus on us to make sure that with all of the intraoperative CT capabilities now, you have to make sure you have it right.” Older technologies like fluoroscopy are flawed and do not guarantee accurate screw placement, but intraoperative CT has improved the ability to determine safe screw placement, albeit at a cost of increased radiation to the patient, he noted. #roboticsurgery #surgicalcomplications #medtech #medicaldevices

What are the benefits you get from a MedTech Strategist Innovation Summit conference? These conferences offer unparalleled opportunities to learn from esteemed speakers and panelists who are at the forefront of medical technology innovation. These industry experts provide invaluable insights into the latest trends, challenges, and breakthroughs, equipping you with the knowledge to stay ahead in the rapidly evolving MedTech landscape. You also get the exclusive opportunity to engage with thought leaders who are shaping the future of #MedTech directly and intimately. By learning from their experiences and success stories, you can gain practical strategies and actionable advice to drive your own innovations and business growth. Furthermore, networking with Venture Capitalists at the summit is crucial for anyone looking to secure funding for their projects. VCs bring not only financial support but also mentorship, industry connections, and strategic guidance. Building relationships with these investors can accelerate your path to market, help you navigate #regulatory hurdles, and provide the resources needed to scale your business. Industry leaders rely on our global investment and networking conferences. Make unique connections, fundraise, stay informed, partner, and learn from the innovators of the #MedTech scene at the industry's longest-running and most intimate conference. Meet our confirmed speakers and panelists (with more coming soon!) for Innovation Summit San Diego 2024: https://bit.ly/3W2UKO2 Ready to get started? Register for #InnovationSanDiego now: https://bit.ly/3W2UKO2 Lu Zhang, Biren Mehta

Israeli start-up Magenta Medical Ltd., led by David Israeli, MD, is making headway toward becoming a disruptive player in the percutaneous left ventricular assist device (pLVAD) market. Today, that market is all but dominated by Abiomed’s (acquired by Johnson & Johnson in a $16.6 billion deal) Impella CP device, but Israeli has reason to believe that Magenta’s Elevate may be able to tip the scales with evidence of strong safety and performance profiles. Read more about how Magenta is the first company in some time to successfully complete a feasibility study in the US, despite ample competition: https://bit.ly/45Y9S3U #medtech #medicaldevices #medtechinnovation

Fill in the blank: The efficacy of endobariatric interventions far exceeds the _____ degree of total body weight loss deemed to be disease-modifying in terms of cardiometabolic risk factors, or the 10% TBWL threshold shown to yield improvements in cardiovascular disease outcomes, liver fibrosis, and glycemic control. Furthermore, the effects from the endobariatric procedures are far more durable than those of weight-loss drugs. Until recently, they were clearly superior in terms of the degree of #weightloss as well. At the recent Digestive Disease Week, #GI endoscopists paraded data showing that interventional weight loss procedures are still more cost-effective by a wide margin than semaglutide and with more durable effects. The meeting also highlighted duodenal mucosal resurfacing, a new type of metabolic surgery with the potential to put type 2 diabetes into remission. Shelby Sullivan, MD, Vivek Kumbhari MD PhD, Harith Rajagopalan, #medtech #medicaldevices

Each year, at MedTech Strategist’s Innovation Summit in Dublin, we present “MedTech by the Numbers,” a panel session where we ask VCs to identify trends inherent in the previous year’s investment and M&A activity. To set the stage for the discussion, we consulted Silicon Valley Bank’s (SVB) 2023 annual report, “Healthcare Investments and Exits,” covering biopharma, healthtech, diagnostics, and medical devices (see Figures 1 and 2 below). 2023 saw a continuation of the decline—for #medtech, in deal volume, size of funding rounds, and valuations—that began after a peak year in 2021. The phenomenon wasn’t limited to #medicaldevices, however. According to the SVB report, taking into account all #healthcare sectors, the level of investment was down 55% from the 2021 peak, and on the whole, the IPO market was flat, compared to 2022. Jennifer McMahon, Inga D., Megan MacDonagh, Anne Portwich, Sylvain Sachot, Stephen Levin, David Cassak

An insightful summary of the panel presided over by Jennifer McMahon during the MedTech Strategist Innovation Summit. Thanks Inga D., Megan MacDonagh, Anne Portwich and Sylvain Sachot for the captivating discussion about trends in 2023, and the future of funding. Looking forward to next years summit now! Read more about our panel here : https://lnkd.in/eYzCPH5s

While complications are extremely rare from robotic surgery failures, they have the potential to be catastrophic. Guidelines for reducing them, excerpted from our recent feature, “Safety in Spine Surgery.” Read more below. ⬇ #medtech #medicaldevices

What is the percentage of #spinalfusion surgeries failing to relieve low back and leg pain? 40%. Neuromodulation therapy is a validated treatment for neuropathic pain, but a means of stimulating the nerves directly in combination with the established TLIF procedure had never been attempted in a clinical trial. After developing the concept, the team built an extensive IP portfolio encompassing more than 80 international patents that cover both the proprietary stimulation device and the procedure to implant it. Founded in 2018 by Justin Zenanko, Nazmi Peyman, MD, and Gregory F. Molnar, PhD, SynerFuse was born from the idea that residual pain that persists after a spinal fusion should be treated at the time of the procedure so patients don’t have to restart the entire pain therapy cycle. Zenanko, a CPA and entrepreneur, and his team worked with neurosurgeons Michael Park, MD, principal investigator, and Rohan Lall, MD, chief medical officer, to invent the Electric Transforaminal Interbody Lumbar Fusion (e-TLIF) implantable stimulation device (see Figure 1). #medicaldevices